DaShenLin Pharmaceutical Group Co., Ltd. (603233.SS)
CNY 16.16
(0.56%)
CNY 16.16
(0.56%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 4.18 Billion CNY | 7.97% |
| 2022 | 3.87 Billion CNY | 6.68% |
| 2021 | 3.63 Billion CNY | 35.33% |
| 2020 | 2.68 Billion CNY | 30.53% |
| 2019 | 2.05 Billion CNY | 8.96% |
| 2018 | 1.88 Billion CNY | 9.87% |
| 2017 | 1.71 Billion CNY | 31.56% |
| 2016 | 1.3 Billion CNY | 29.18% |
| 2015 | 1.01 Billion CNY | 33.63% |
| 2014 | 755.84 Million CNY | 5.13% |
| 2013 | 718.98 Million CNY | 50.73% |
| 2012 | 477 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 4.2 Billion CNY | -1.82% |
| 2024 Q1 | 4.34 Billion CNY | 3.9% |
| 2024 Q2 | 4.28 Billion CNY | -1.38% |
| 2023 Q2 | 4.13 Billion CNY | -2.65% |
| 2023 Q3 | 4.27 Billion CNY | 3.49% |
| 2023 Q4 | 4.18 Billion CNY | -2.27% |
| 2023 FY | 4.18 Billion CNY | 7.97% |
| 2023 Q1 | 4.24 Billion CNY | 9.66% |
| 2022 Q4 | 3.87 Billion CNY | 12.29% |
| 2022 Q3 | 3.44 Billion CNY | 0.3% |
| 2022 Q1 | 3.6 Billion CNY | -0.63% |
| 2022 FY | 3.87 Billion CNY | 6.68% |
| 2022 Q2 | 3.43 Billion CNY | -4.68% |
| 2021 Q4 | 3.63 Billion CNY | 6.17% |
| 2021 FY | 3.63 Billion CNY | 35.33% |
| 2021 Q2 | 2.99 Billion CNY | 3.04% |
| 2021 Q1 | 2.9 Billion CNY | 8.22% |
| 2021 Q3 | 3.41 Billion CNY | 14.3% |
| 2020 Q1 | 2.31 Billion CNY | 12.73% |
| 2020 Q2 | 2.19 Billion CNY | -5.41% |
| 2020 Q4 | 2.68 Billion CNY | 7.32% |
| 2020 FY | 2.68 Billion CNY | 30.53% |
| 2020 Q3 | 2.49 Billion CNY | 14.07% |
| 2019 Q1 | 2.04 Billion CNY | 8.34% |
| 2019 FY | 2.05 Billion CNY | 8.96% |
| 2019 Q2 | 1.98 Billion CNY | -2.87% |
| 2019 Q4 | 2.05 Billion CNY | 3.84% |
| 2019 Q3 | 1.97 Billion CNY | -0.27% |
| 2018 Q1 | 1.66 Billion CNY | -3.2% |
| 2018 Q2 | 1.79 Billion CNY | 7.77% |
| 2018 Q3 | 1.94 Billion CNY | 8.86% |
| 2018 Q4 | 1.88 Billion CNY | -3.26% |
| 2018 FY | 1.88 Billion CNY | 9.87% |
| 2017 Q4 | 1.71 Billion CNY | 9.23% |
| 2017 Q2 | 1.39 Billion CNY | 3.36% |
| 2017 Q3 | 1.57 Billion CNY | 12.84% |
| 2017 Q1 | 1.34 Billion CNY | 3.28% |
| 2017 FY | 1.71 Billion CNY | 31.56% |
| 2016 FY | 1.3 Billion CNY | 29.18% |
| 2016 Q4 | 1.3 Billion CNY | 0.0% |
| 2016 Q1 | - CNY | -100.0% |
| 2015 FY | 1.01 Billion CNY | 33.63% |
| 2015 Q4 | 1.01 Billion CNY | 0.0% |
| 2015 Q1 | 814.88 Million CNY | 0.0% |
| 2015 Q2 | 814.88 Million CNY | 0.0% |
| 2014 FY | 755.84 Million CNY | 5.13% |
| 2013 FY | 718.98 Million CNY | 50.73% |
| 2012 FY | 477 Million CNY | 0.0% |